Protagonist Therapeutics logo
Protagonist Therapeutics PTGX
$ 41.53 2.15%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Protagonist Therapeutics EBITDA per Share 2011-2024 | PTGX

Annual EBITDA per Share Protagonist Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.63 -2.66 -2.7 -1.85 -3.01 -1.87 -2.12 -4.98 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.63 -4.98 -2.6

Quarterly EBITDA per Share Protagonist Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 3.39 - - - -0.71 - -0.64 -0.84 -0.43 - -0.69 -0.69 -0.54 - -0.19 -0.54 -0.7 -0.64 -0.62 -1.26 -0.6 -0.66 -0.39 -0.42 -0.39 -0.17 -0.28 -0.89 -0.85 -0.68 -0.81 -18.1 -24.2 -18.4 -14.2 -12.7 - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
3.39 -24.2 -3.29